Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19

Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19

Bibliographic Details
Main Authors: Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
COVID-19
lysosomotropic compounds
approved active compounds
cytokine storm syndrome
lysosomotropism
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.584881/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.584881/full

Similar Items